Multidimensional Analysis of Risk Factors for the Severity and Mortality of Patients with COVID-19 and Diabetes

ConclusionsMore attention should be paid to patients with COVID-19 and diabetes, especially when they have high leukocyte counts (> 5.37 × 109/L). Timely and adequate intravenous immunoglobulin (IVIG) use may reduce the mortality of critical patients with COVID-19 and diabetes.

http://link.springer.com/10.1007/s40121-020-00359-6

Source: Infectious Diseases and Therapy - October 28, 2020 Category: Infectious Diseases Source Type: research